Navigation Links
Medical Device Consultants, Inc. Welcomes Brian Edwards, Senior Regulatory Staff Consultant
Date:7/19/2011

NORTH ATTLEBORO, Mass., July 19, 2011 /PRNewswire/ -- Medical Device Consultants, Inc. (MDCI), a leading regulatory consulting firm and CRO for the medical device industry, announced today that Mr. Brian Edwards has joined the company's regulatory services group as a senior regulatory staff consultant. He will be based in Minneapolis, MN.

Mr. Edwards brings over twenty years of experience in the regulation of medical devices, design and analysis of device trials, biostatistics, quality systems, and US and OUS regulatory submissions. His work spans a broad range of therapeutic areas including work with spinal, audiological, cardiovascular, cardiology, muscle and nerve stimulation, urological, and software/communication devices.  During his previous positions as director of regulatory affairs at Zimmer Spine, Inc., Otologics, LLC, and Stereotaxis, Inc., as well as a senior level position with Medtronic, Inc. he managed regulatory clearances and approvals for Class II and Class III devices in the United States, European Union, Canada, Latin America and Asia. In addition, he is experienced in the implementation and auditing of FDA and ISO compliant quality systems.  

"I am pleased to welcome Brian to our team," said Vicki Anastasi, vice president of regulatory services and business development. "He brings proven regulatory expertise in key therapeutic areas, including cardiovascular, orthopedics and medical device software. Based in Minneapolis, he will amplify MDCI's presence in the important Twin Cities medical device cluster."

Brian holds a B.S. in chemical engineering, and an M.S. in biomedical engineering, both from the University of Minnesota. He also earned an M.S. in biostatistics from the University of California, Los Angeles.  Brian is a member of the Regulatory Affairs Professionals Society (RAPS).

About MDCI

Founded in 1980, MDCI is a full-service regulatory consulting firm and contract research organization (CRO) that helps emerging and established firms commercialize novel and innovative medical devices, in vitro diagnostics, and combination products.  Clients trust MDCI to deliver customized strategic guidance and creative "hands-on" solutions to address their unique regulatory, clinical trial, and quality assurance challenges at every stage of the product lifecycle.  MDCI has helped hundreds of clients conduct successful clinical trials, achieve regulatory clearance and approval, and maintain compliance for products in the U.S. and internationally.  MDCI has offices in Massachusetts and California.  Additional information is available at www.mdci.com.


'/>"/>
SOURCE Medical Device Consultants, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. FDA Outlines Oversight of Mobile Medical Applications
2. China Sky One Medical Wins Bidding Process on Land Use Rights Covering Land at Song Bei District in Harbin
3. Key Challenges for Pharma Medical Affairs Functions Include Budget & Headcounts
4. AAPC Physician Services Announces Medical Compliance Toolkit
5. European Medical Displays Markets
6. China Medical Technologies Announces the Filing of its Annual Report on Form 20-F for the Fiscal Year Ended March 31, 2011 with the SEC
7. HASCO Medical Announces New Redesigned Websites for Mobility Freedom and Wheelchair Vans of America
8. Mindray Medical Provides Mid-Year Update on Product Development
9. Aethlon Medical Releases Shareholder Letter
10. Aprima Earns High Marks at Holy Name Medical Center
11. QuantRx Biomedical Corporation Provides Corporate Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... HILLS, Calif. , June 23, 2016 Any ... the many challenges of the current process. Many of them ... because of the technical difficulties and high laboratory costs involved. ... have to offer it at such a high cost that ... afford it. Dr. Parsa Zadeh , founder ...
(Date:6/23/2016)... -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that ... PCT (procalcitonin) assay as a dedicated testing solution for ... clearance, Roche is the first IVD company in the ... risk assessment and management. PCT is a ... in blood can aid clinicians in assessing the risk ...
(Date:6/23/2016)... June 23, 2016 Research and Markets ... Issue 52" report to their offering. ... treatment creates a favourable commercial environment for MedImmune to enter. ... base that will serve to drive considerable growth for effective ... serve to cap sales considerably, but development is still in ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from the ... AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes Convention Center in ... topics including advance care planning, healthcare costs and patient and family engagement. , ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library ... City Observer , brings up a new, often overlooked aspect of head lice: the parasite’s ... for fumigation is not a common occurrence, but a necessary one in the event that ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room ... Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. ... of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. ... from injury. Recently, he has implemented orthobiologic procedures as a method for treating ... one of the first doctors to perform the treatment. Orthobiologics are substances that ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the ... In terms of the latter, setting the bar too high can result in disappointment, ... just slow progress toward their goal. , Research from PsychTests.com reveals ...
Breaking Medicine News(10 mins):